Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder

AbstractObjective To evaluate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) and liver metastases adjacent to the gallbladder (GB).Materials and methods A total of 113 patients with 118 liver lesions (63 HCC les...

Full description

Bibliographic Details
Main Authors: Yuanfeng Meng, Binbin Jiang, Kun Yan, Song Wang, Zhongyi Zhang, Luzeng Chen, Wei Wu, Wei Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2023.2182748
_version_ 1797374264710529024
author Yuanfeng Meng
Binbin Jiang
Kun Yan
Song Wang
Zhongyi Zhang
Luzeng Chen
Wei Wu
Wei Yang
author_facet Yuanfeng Meng
Binbin Jiang
Kun Yan
Song Wang
Zhongyi Zhang
Luzeng Chen
Wei Wu
Wei Yang
author_sort Yuanfeng Meng
collection DOAJ
description AbstractObjective To evaluate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) and liver metastases adjacent to the gallbladder (GB).Materials and methods A total of 113 patients with 118 liver lesions (63 HCC lesions and 55 liver metastases) adjacent to the gallbladder underwent RFA between March 2011 and June 2019. Gallbladder-related complications and technique effectiveness rates were evaluated based on the classification of liver tumors and the distance between the lesion and the gallbladder.Results Gallbladder-related complications were observed in 13 patients. Among the patients with HCC, there was no significant difference between the ≤0.5 cm and >0.5 cm groups (p = .282). However, among the patients with liver metastases, the incidence of gallbladder-related complications in the ≤0.5 cm group was significantly higher than that in the >0.5 cm group (p = .025). The overall incidence of complications was significantly higher in the ≤0.5 cm group than in the >0.5 cm group (p = .020). Among the patients with lesions ≤3 cm, the technical effectiveness rate in the HCC group was significantly higher than in the liver metastasis group (p = .036).Conclusion RFA is a safe and effective treatment option for liver tumors adjacent to the gallbladder. Patients with lesions ≤0.5 cm from the gallbladder had higher gallbladder-related complications, especially patients with liver metastases. Among patients with lesions ≤3 cm, RFA showed greater technical effectiveness for treating HCC than for treating liver metastases.
first_indexed 2024-03-08T19:03:21Z
format Article
id doaj.art-fcb8479fee884a77b9314a2981d6065d
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-03-08T19:03:21Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-fcb8479fee884a77b9314a2981d6065d2023-12-28T04:15:43ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572023-12-0140110.1080/02656736.2023.2182748Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladderYuanfeng Meng0Binbin Jiang1Kun Yan2Song Wang3Zhongyi Zhang4Luzeng Chen5Wei Wu6Wei Yang7Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaDepartment of Ultrasound, Peking University First Hospital, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Ultrasound, Peking University Cancer Hospital & Institute, Beijing, ChinaAbstractObjective To evaluate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) and liver metastases adjacent to the gallbladder (GB).Materials and methods A total of 113 patients with 118 liver lesions (63 HCC lesions and 55 liver metastases) adjacent to the gallbladder underwent RFA between March 2011 and June 2019. Gallbladder-related complications and technique effectiveness rates were evaluated based on the classification of liver tumors and the distance between the lesion and the gallbladder.Results Gallbladder-related complications were observed in 13 patients. Among the patients with HCC, there was no significant difference between the ≤0.5 cm and >0.5 cm groups (p = .282). However, among the patients with liver metastases, the incidence of gallbladder-related complications in the ≤0.5 cm group was significantly higher than that in the >0.5 cm group (p = .025). The overall incidence of complications was significantly higher in the ≤0.5 cm group than in the >0.5 cm group (p = .020). Among the patients with lesions ≤3 cm, the technical effectiveness rate in the HCC group was significantly higher than in the liver metastasis group (p = .036).Conclusion RFA is a safe and effective treatment option for liver tumors adjacent to the gallbladder. Patients with lesions ≤0.5 cm from the gallbladder had higher gallbladder-related complications, especially patients with liver metastases. Among patients with lesions ≤3 cm, RFA showed greater technical effectiveness for treating HCC than for treating liver metastases.https://www.tandfonline.com/doi/10.1080/02656736.2023.2182748Hepatocellular carcinomaliver metastasesradiofrequency ablationgallbladdersafetyefficacy
spellingShingle Yuanfeng Meng
Binbin Jiang
Kun Yan
Song Wang
Zhongyi Zhang
Luzeng Chen
Wei Wu
Wei Yang
Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
International Journal of Hyperthermia
Hepatocellular carcinoma
liver metastases
radiofrequency ablation
gallbladder
safety
efficacy
title Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
title_full Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
title_fullStr Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
title_full_unstemmed Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
title_short Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
title_sort evaluation of the safety and efficacy of ultrasound guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
topic Hepatocellular carcinoma
liver metastases
radiofrequency ablation
gallbladder
safety
efficacy
url https://www.tandfonline.com/doi/10.1080/02656736.2023.2182748
work_keys_str_mv AT yuanfengmeng evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT binbinjiang evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT kunyan evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT songwang evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT zhongyizhang evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT luzengchen evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT weiwu evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder
AT weiyang evaluationofthesafetyandefficacyofultrasoundguidedpercutaneousradiofrequencyablationforhepatocellularcarcinomaandlivermetastasesadjacenttothegallbladder